Ranked one of the best clinical decision support tools for health professionals worldwide, BMJ Best Practice provides step-by-step guidance on diagnosis, treatment and prevention.

Updated daily using robust evidence-based methodology and expert opinion, BMJ Best Practice provides you with access to the very latest clinical information.

Important updates

23 Aug 2024
important notification HIV infection in pregnancy
21 Aug 2024
important notification Mpox
07 Aug 2024
important notification Eczema
31 Jul 2024
important notification Asthma in adults
23 Aug 2024

Dolutegravir recommended as the preferred HIV treatment in pregnancy

Guidelines published by the US Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission now recommend dolutegravir plus a dual nucleoside reverse transcriptase inhibitor (NRTI) backbone as the preferred antiretroviral therapy (ART) for women with HIV infection who are pregnant or trying to conceive.

21 Aug 2024

WHO declares mpox a public health emergency of international concern for the second time

The World Health Organization (WHO) declared the current mpox outbreak in Africa a public health emergency of international concern (PHEIC) on the 14th August 2024. PHEIC status aims to accelerate funding, research, and international public health measures and co-operation to contain a disease, and is the WHO’s highest level of alert possible.

07 Aug 2024

New guidelines for use of systemic therapies in eczema

​The American Academy of Dermatology has updated their 2014 guidelines of care for the management of eczema in adults with phototherapy and systemic therapies.

31 Jul 2024

UK MHRA reiterates montelukast safety warning

A drug safety update from the UK Medicines and Healthcare products Regulatory Agency (MHRA) reminds prescribers of the potential risk of neuropsychiatric adverse events in patients receiving montelukast, including:

The highest ranking* CDS app

Access clinical information anywhere, even offline, with our award-winning app.

Whether you’re on the ward, at home, or studying, the BMJ Best Practice app gives you trusted decision support information in an instant. The app is provided for free to those who have a personal subscription to BMJ Best Practice or have access provided by their institution.

* As of 23 August 2023

...
...
Qoute

It’s no understatement to say that this app (and the website) is responsible for getting me through medical school. Nowhere else can you get such succinct and relevant summaries and treatment algorithms.

BMJ Best Practice app user
...

Introducing our new Frailty topic

Unlock essential insights into frailty with the latest addition to BMJ Best Practice

Recognising frailty is crucial. It’s an independent risk factor for adverse health outcomes, such as increased hospitalisations. By identifying frailty, we can tailor interventions to mitigate risks and improve outcomes. This topic is designed to equip you with the tools you need to navigate the complexities of frailty management, by helping you to:

  • Identify frailty
  • Navigate an ageing population
  • Understand the implications of frailty
  • Support the MDT
highlighted

Have you used our Comorbidities Manager?

Managing the treatment of patients with comorbidities is hard – clinical guidelines only focus on single conditions – but failure to manage comorbidities leads to worse clinical outcomes and longer lengths of stay.

Our unique Comorbidities Manager* provides guidance on the treatment of a patient’s acute condition alongside their preexisting comorbidities.

*This feature is only available if your institution has purchased the Comorbidities Manager. If you have access it will appear under the ‘Your Profile’ section in the menu at the top of the page.

At a glance

At a glance

One in three adults suffer from multiple chronic conditions and most patients in the acute setting have more than one medical condition.

  • Treat patients with comorbidities with confidence
  • Better understand the complexities of treating multiple conditions
  • Achieve better outcomes for patients